Short Interest in Guardian Pharmacy Services, Inc. (NYSE:GRDN) Rises By 33.3%

Guardian Pharmacy Services, Inc. (NYSE:GRDN) was the target of a significant growth in short interest during the month of January. As of January 15th, there was short interest totaling 1,543,962 shares, a growth of 33.3% from the December 31st total of 1,158,683 shares. Based on an average daily volume of 280,436 shares, the days-to-cover ratio is presently 5.5 days. Currently, 6.7% of the shares of the stock are short sold. Currently, 6.7% of the shares of the stock are short sold. Based on an average daily volume of 280,436 shares, the days-to-cover ratio is presently 5.5 days.

Guardian Pharmacy Services Stock Down 2.0%

GRDN opened at $31.73 on Wednesday. Guardian Pharmacy Services has a 12 month low of $17.78 and a 12 month high of $37.43. The company has a fifty day simple moving average of $30.17 and a 200 day simple moving average of $27.30. The stock has a market cap of $2.01 billion, a P/E ratio of 50.36 and a beta of 0.96.

Guardian Pharmacy Services (NYSE:GRDN) last released its quarterly earnings data on Monday, November 10th. The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.01. Guardian Pharmacy Services had a return on equity of 30.29% and a net margin of 2.90%.The business had revenue of $377.43 million for the quarter, compared to analysts’ expectations of $381.16 million. On average, equities research analysts expect that Guardian Pharmacy Services will post 0.87 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have commented on the company. Wall Street Zen upgraded Guardian Pharmacy Services from a “buy” rating to a “strong-buy” rating in a research report on Monday, November 17th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Guardian Pharmacy Services in a research report on Monday, December 29th. Truist Financial upped their target price on shares of Guardian Pharmacy Services from $30.00 to $34.00 and gave the company a “buy” rating in a research report on Friday, November 14th. Stephens lifted their price target on shares of Guardian Pharmacy Services from $35.00 to $36.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 14th. Finally, Oppenheimer initiated coverage on shares of Guardian Pharmacy Services in a report on Friday, October 10th. They issued an “outperform” rating and a $30.00 price objective on the stock. Four equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $32.00.

Institutional Investors Weigh In On Guardian Pharmacy Services

A number of hedge funds and other institutional investors have recently bought and sold shares of GRDN. Dynamic Technology Lab Private Ltd bought a new position in shares of Guardian Pharmacy Services during the 1st quarter worth approximately $233,000. KLP Kapitalforvaltning AS acquired a new position in Guardian Pharmacy Services during the second quarter worth $75,000. Allspring Global Investments Holdings LLC boosted its holdings in Guardian Pharmacy Services by 0.5% during the second quarter. Allspring Global Investments Holdings LLC now owns 285,885 shares of the company’s stock worth $6,092,000 after purchasing an additional 1,338 shares during the last quarter. Stephens Inc. AR bought a new position in Guardian Pharmacy Services in the second quarter valued at $776,000. Finally, Kornitzer Capital Management Inc. KS bought a new position in Guardian Pharmacy Services in the second quarter valued at $1,066,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.